Article Information
History
- November 16, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY 4.0 International license.
Author Information
- Takalani Girly Nemungadi1,*,
- Elisabeth Kleppa2,
- Hashini Nilushika Galappaththi-Arachchige2,
- Pavitra Pillay3,
- Svein Gunnar Gundersen4,
- Birgitte Jyding Vennervald5,
- Patricia D. Ndhlovu6,
- Myra Taylor1,
- Saloshni Naidoo1 and
- Eyrun F. Kjetland1,2
- 1Discipline of Public Health Medicine, College of Health Sciences, University of KwaZulu-Natal, Durban, South Africa
- 2Norwegian Centre for Imported and Tropical Diseases, Oslo University Hospital, Oslo, Norway
- 3Department of Biomedical and Clinical Technology, Durban University of Technology, KwaZulu-Natal, South Africa
- 4Institute for Global Development and Planning, University of Agder, Kristiansand, Norway
- 5Section for Parasitology and Aquatic Pathobiology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
- 6BRIGHT Academy, Ugu District, South Africa
- ↵*Corresponding author: Takalani Girly Nemungadi, University of KwaZulu-Natal, School of Nursing and Public Health, Durban, South Africa, 4041 (Email: takalaninemungadi{at}gmail.com)
Posted November 16, 2023.
PREDICTORS FOR PARTICIPATION IN MASS-TREATMENT AND FEMALE GENITAL SCHISTOSOMIASIS RE-INVESTIGATION, AND THE EFFECT OF PRAZIQUANTEL TREATMENT IN SOUTH AFRICAN ADOLESCENTS
